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Activation of antiviral responses by RNA sensors RIG-I andMDA5must be stringently controlled. In this issue
of Immunity, Wies et al. (2013) show that a requirement for activation-induced dephosphorylation of these
proteins reinforces this restriction.Cells sense viral RNA by one of two struc-
turally related sensor proteins of the RIG-
I-like receptor (RLR) family—RIG-I and
MDA5.
The best-studied signaling functions of
the RLRs are those initiated by their
induced binding to MAVS (also known as
IPS-1, CARDIF, or VISA), an adaptor
protein anchored to the outer membrane
of the mitochondrion. Once activated,
MAVS initiates a number of antiviral
signaling pathways, most notably those
of transcription factors IRF3 (via protein
kinases TBK1 and IKKε) and NF-kB.
To allow effective sparking of this anti-
viral response even by small numbers of
viral particles, MAVS activation unfolds
explosively. Self-association of just a few
MAVS molecules, once bound with
RLRs, triggers an avalanche of their
aggregation and hence also their massive
activation (Hou et al., 2011).
This vehement initiation of cellular
changes would cause great harm to the
host if it were induced unnecessarily.
Therefore, besides including the core
MAVS components that mediate its
signaling activity, this signaling complex
contains accessory proteins that restrain
its function (Ramos and Gale, 2011). The
study by Wies et al. (2013) in this issue
of Immunity describes a mechanism that
affects the functioning of the MAVS
complex in this way. The mechanism,
rather than operating after MAVS is acti-
vated by RLRs, exerts its effects on the
RLRs themselves.
Signaling by both RIG-I and MDA5 is
triggered by their binding to MAVS
through two caspase activation and
recruitment domains (CARDs) located in
tandem at their N termini. In addition,402 Immunity 38, March 21, 2013 ª2013 Elsethese molecules contain a central DExD/
H-box helicase domain and a C-terminal
domain (CTD). Some mechanisms that
restrict the function of these RLRs
upstream of MAVS activation have
already been described. First, their struc-
ture dictates their folding into an autoinhi-
bited form. In the absence of stimulation,
accessibility of the CARDs is restricted
by constitutive binding of one of them to
the DExD/H-box. This state is altered
upon infection. Binding of viral nucleic
acid, first to the CTD and then to
the DExD/H-box domain, releases the
CARDs via a process facilitated by
ATPase activity of the DExD/H-box
domain (Kolakofsky et al., 2012). Their
release is a necessary condition for
enabling the CARDs to activate MAVS.
However, it does not suffice for the
purpose; another structural change is still
needed and is imposed by the binding of
K63-linked polyubiquitin chains to
specific sites in the RLRs. This binding
dictates clustering of RIG-I and MDA5
into oligomeric structures; it perhaps
also causes conformational changes in
these proteins, as a result of which they
acquire the ability to activate MAVS (Jiang
et al., 2012). In the case of RIG-I, the
activating polyubiquitin chains are gener-
ated by the actions of two E3 ubiquitin
ligases, TRIM25 and RNF135 (Riplet).
TRIM25 is recruited to the CARDs upon
their exposure, and it then links a polyubi-
quitin chain to a specific lysine residue in
the RIG-I CARDs and possibly also gener-
ates free polyubiquitin chains. RNF135
binds to the CTD. The mechanism of
generation of the polyubiquitin chains
that are required for activation of MDA5
is unknown.vier Inc.The findings presented by Wies et al.
(2013) in the present issue, as well as in
other publications by this group (Nistal-
Villa´n et al., 2010; Gack et al., 2010),
reveal that activation of MAVS by the
RLRs is further restricted by the need for
another covalent modification. Certain
serine and threonine residues in the
CARDs of RIG-I and MDA5 were previ-
ously found to be constitutively phosphor-
ylated prior to stimulation. For the RLRs to
be activated, these phosphate groups
must be removed. The dephosphorylation
is mediated by two specific protein phos-
phatases, PP1a and PP1g (but not PP1b),
which are recruited to the sensor mole-
cules after RNA binds to them.
The data suggest that the dephosphor-
ylation occurs as a consequence of expo-
sure of the CARDs upon viral RNA binding
and precedes the binding of TRIM25 to
RIG-I. In an independent study, inhibitory
phosphorylation that is reversed by phos-
phatases upon viral infection has also
been shown to occur in the CTD of RIG-I
(Sun et al., 2011).
Activation of the RLRs thus apparently
occurs through the sequential release
of a series of inhibitory latches, each
imposed by a different set of molecules:
a conformational change dictated by
the binding of viral RNA to the RLRs;
binding of phosphatase to specific sites
on RLRs exposed by this conformational
change and dephosphorylation of speci-
fic residues in them; and activation of
E3 ligases and binding of K63-linked
polyubiquitin chains to the dephos-
phorylated receptors, resulting in the
assembly of RLR molecules to a multimo-
lecular form capable of activating MAVS
(Figure 1).
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Figure 1. Activation of the RIG-I-like Receptors Necessitates Their Dephosphorylation
Activation of RIG-I and MDA5 occurs through a sequentially dependent series of conformational changes and covalent modifications. In the nonstimulated state,
one of the two CARDs in these RLRs is bound to the DExD/H-box helicase domain, thus maintaining these RIG-I and MDA5 molecules in an autoinhibited form.
Several serine and threonine residues in the molecules are constitutively phosphorylated. Binding of viral nucleic acid releases the CARDs in a process facilitated
by ATPase activity of the DExD/H-box domain. This conformational change provides protein phosphatases with access to distinct binding sites in the RLRs.
Dephosphorylation in the CARD is mediated by PP1a and PP1g. The identity of the phosphatases affecting the CTD is unknown. Dephosphorylation of the
RLRs allows activation of E3 ubiquitin ligases, which generate K63-linked polyubiquitin chains. In the case of RIG-I, the E3 ligases are TRIM25, which binds
to the dephosphorylated CARDs, and RNF135 (Riplet), which binds to the CTD. The E3 enzymes affectingMDA5 are still unknown. Binding of polyubiquitin chains
to the dephosphorylated RLRs induces their oligomerization and binding to the adaptor protein MAVS. This binding triggers activation of MAVS molecules,
leading to an antiviral state and inflammation.
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PreviewsDoes the regulation of RLR function
through phosphorylation and dephos-
phorylation indeed serve as a safeguard
against excessive responses and as
a mode of adjustment to need? Accord-
ing to the data of Wies et al. (2013),
recruitment of phosphatase(s) to the
RLRs occurs passively, merely as
a consequence of exposure of their bind-
ing sites on the CARDs of the RLRs. It is
not clear, however, whether the phos-
phatase availability or activity (or both)
depends on other signals or whether their
availability and function can be modu-
lated by regulatory proteins. There is
also no information on whether the activ-
ities of the protein kinases responsible
for phosphorylation of the RLRs are
subject to modulation (in the case of
RIG-I, PKC-a and PKC-b phosphorylate
the regulatory residues in the CARD
[Maharaj et al., 2012] and casein kinase
II phosphorylates those in the CTD [Sun
et al., 2011]).For gaining a better understanding of
the implications of this regulation of
RLR function, research will be needed
to further clarify the regulation of the
protein kinases and phosphatases
affecting the RLRs and to reveal what
additional proteins participate in this
regulation. Also needed is more informa-
tion about the conformational changes
imposed on the RLRs by their phos-
phorylation and about the full range of
functional consequences of such
phosphorylation.
Detection of foreign nucleic acids in the
cytoplasm by specific sensor proteins
and activation of defense mechanisms
by these proteins are among the principal
modes of protection against infection.
The discovery that phosphorylation and
dephosphorylation of specific residues in
such sensors play decisive roles in their
activation provides an exciting point of
view of their function, and further explora-
tion is warranted.Immunity 3REFERENCES
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